Nicotine, cigarette smoking and cardiac arrhythmia: An overview

European Journal of Preventive Cardiology

Volumn 19, Issue 3, 2012, Pages 297-305

  D'Alessandro, Alessandra ^a   Boeckelmann, Irina ^a   Hammwhöner, Matthias ^b   Goette, Andreas ^a,b  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

^b St Vincenz Hospital   (Germany)

Author keywords

atrial fibrillation; cardiac arrhythmia; cardiovascular disease; cigarette smoking; Nicotine; risk factors; tobacco

Indexed keywords

CARBON MONOXIDE; NICOTINE;

ATHEROSCLEROSIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; CLINICAL TRIAL; CORONARY ARTERY DISEASE; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL TOBACCO SMOKE; HEART ARRHYTHMIA; HUMAN; OXIDATIVE STRESS; PASSIVE SMOKING; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; UNITED STATES;

ANIMALS; ARRHYTHMIAS, CARDIAC; DEATH, SUDDEN, CARDIAC; HEART CONDUCTION SYSTEM; HUMANS; NICOTINE; NICOTINIC AGONISTS; RISK ASSESSMENT; RISK FACTORS; SMOKING; SMOKING CESSATION; TOBACCO SMOKE POLLUTION;

EID: 84865561111     PISSN: 20474873     EISSN: None     Source Type: Journal    
DOI: 10.1177/1741826711411738     Document Type: Review

References (73)

1. US Department of Health and Human Services, Centers for Disease Control and Prevention. Atlanta: National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health ; 2004 :
2. Tonstad S, Johnston JA. Cardiovascular risks associated with smoking: a review for clinicians. Eur J Cardiovasc Prev Rehabil. 2006 ; 13: 507-514 (Pubitemid 44162150)
3. Benowitz NL, Hansson A, Jacob 3rd, P. Smoking cardiovascular effects of nasal and transdermal nicotine and cigarette smoking. Hypertension. 2002 ; 39: 1107-1112 (Pubitemid 34620132)
4. Benowitz NL. Pharmacology of nicotine: addiction, smoking induced diseases, and therapeutics. Annu Rev Pharmacol Toxicol. 2009 ; 49: 67-71
5. Benowitz NL. Pharmacologic aspects of cigarette smoking and nicotine addiction. N Engl J Med. 1988 ; 319: 1318-1330 (Pubitemid 19003394)
6. Fattinger K, Verotta D, Benowitz NL. Pharmacodynamics of acute tolerance to multiple nicotinic effects in humans. J Pharmacol Exp Ther. 1997 ; 281: 1238-1246 (Pubitemid 27258383)
7. Falk JA, Kadiev S, Criner GJ, Scharf SM, Minai OA, Diaz P. Cardiac disease in chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2008 ; 5: 543-548 (Pubitemid 351669184)
8. Mehta MC, Jain AC, Mehta A, Billie M. Cardiac arrhythmias following intravenous nicotine: experimental study in dogs. J Cardiovasc Pharmacol Ther. 1997 ; 2: 291-298 (Pubitemid 27469369)
9. Wang H, ShiH, Zhang L, Pourrier M, Yang B, Nattel S, et al. Nicotine is a potent blocker of the cardiac A-type K+ channels: effects on cloned Kv4.3 channels and native transient outward current. Circulation. 2000 ; 102: 1165-1171
10. Beaummont J, Michaels DC, Delmar M, Davidenko J, Jalife J. A model study of changes in excitability of ventricular muscle cells: inhibition, facilitation, and hysteresis. Am J Physiol. 1995 ; 268: H1181 - H1194
11. Wilde AA, Aksnes G. Myocardial potassium loss and cell depolarisation in ischaemia and hypoxia. Cardiovasc Res. 1995 ; 29: 1-15
12. Wang H, Shi H, Wang Z. Nicotine depresses the functions of multiple cardiac potassium channels. Life Sci. 1999 ; 65: 143-149
13. Miyauchi M, Qu Z, Miyauchi Y, Zhou SM, Pak H, Mandel WJ, et al. Chronic nicotine in hearts with healed ventricular myocardial infarction promotes atrial flutter that resembles typical human atrial flutter. Am J Physiol Heart Circ Physiol. 2005 ; 288: H2878 - H2886
14. Manabe I, Shindo T, Nagai R. Gene expression in fibroblasts and fibrosis: involvement in cardiac hypertrophy. Circ Res. 2002 ; 91: 1103-1113 (Pubitemid 36076358)
15. Cucina A, Corvino V, Sapienza P, Borrelli V, Lucarelli M, Scarpa S, et al. Nicotine regulates basic fibroblastic growth factor and transforming growth factor beta1 production in endothelial cells. Biochem Biophys Res Commun. 1999 ; 257: 306-312 (Pubitemid 29301440)
16. Goette A, Lendeckel U, Kuchenbecker A, Bukowska A, Peters B, Klein HU, et al. Cigarette smoking induces atrial fibrosis in humans via nicotine. Heart. 2007 ; 93: 1056-1063 (Pubitemid 47310982)
17. Shan H, Zhang Y, Lu Y, Zhang Y, Pan Z, Cai B, et al. Downregulation of miR-133 and miR-590 contributes to nicotine-induced atrial remodelling in canines. Cardiovasc Res. 2009 ; 83: 465-472
18. Goette A. Nicotine, atrial fibrosis, and atrial fibrillation: do microRNAs help to clear the smoke?. Cardiovasc Res. 2009 ; 83: 421-472
19. Sekhon HS, Jia Y, Raab R, Kuryatov A, Pankow JF, Whitsett JA, et al. Prenatal nicotine increases pulmonary alpha7 nicotinic receptor expression and alters fetal lung development in monkeys. J Clin Invest. 1999 ; 103: 637-647 (Pubitemid 29122416)
20. Sekhon HS, Proskocil BJ, Clark JA, Spindel ER. Prenatal nicotine exposure increases connective tissue expression in foetal monkey pulmonary vessels. Eur Respir J. 2004 ; 23: 906-915 (Pubitemid 38807367)
21. Sekhon HS, Keller JA, Benowitz NL, Spindel ER. Prenatal nicotine exposure alters pulmonary function in newborn rhesus monkeys. Am J Respir Crit Care Med. 2001 ; 164: 989-994 (Pubitemid 32971646)
22. Roman J, Ritzenthaler JD, Gil-Acosta A, Rivera HN, Roser-Page S. Nicotine and fibronectin expression in lung fibroblasts: implications for tobacco-related lung tissue remodeling. FASEB J. 2004 ; 18: 1436-1438 (Pubitemid 39561606)
23. Choragudi NL, Aronow WS, DeLuca AJ. Nicotine gum-induced atrial fibrillation. Heart Dis. 2003 ; 5: 100-101 (Pubitemid 36538665)
24. Nunes JP, Barbosa E, Lopes L, Alves C, Gonçalves FR. Nicotine nasal inhalation, atrial fibrillation and seizures. Cardiology. 2001 ; 96: 58-58
25. Arnaot MR. Treating heart disease. Nicotine patches may not be safe. BMJ. 1995 ; 310: 663-664
26. Rigotti NA, Eagle KA. Atrial fibrillation while chewing nicotine gum. JAMA. 1986 ; 255: 1018-1018
27. Stewart PM, Catterall JR. Chronic nicotine ingestion and atrial fibrillation. Br Heart J. 1985 ; 54: 222-223 (Pubitemid 15012925)
28. Leone A. Biochemical markers of cardiovascular damage from tobacco smoke. Curr Pharm Des. 2005 ; 11: 2199-2208 (Pubitemid 40872710)
29. Benowitz NL, Gourlay SG. Cardiovascular toxicity of nicotine: implications for nicotine replacement therapy. J Am Coll Cardiol. 1997 ; 29: 1422-1431 (Pubitemid 27272432)
30. Kaul B, Calabro J, Hutcheon DE. Effects of carbon monoxide on the vulnerability of the ventricles to drug induced arrhythmias. J Clin Pharmacol. 1974 ; 14: 25-31
31. Aronow WS, Stemmer EA, Wood B, Zweig S, Tsao KP, Raggio L. Carbon monoxide and ventricular fibrillation threshold in dogs with acute myocardial injury. Am Heart J. 1978 ; 95: 754-756 (Pubitemid 9006515)
32. Andre L, Boissière J, Reboul C, Perrier R, Zalvidea S, Meyer G, et al. Carbon monoxide pollution promotes cardiac remodeling and ventricular arrhythmia in healthy rats. Am J Respir Crit Care Med. 2010 ; 181: 587-595
33. Adams KF, Koch G, Chatterjee B, Goldstein GM, O'Neil JJ, Bromberg PA, et al. Acute elevation of blood carboxyhemoglobin to 6% impairs exercise performance and aggravates symptoms in patients with ischemic heart disease. J Am Coll Cardiol. 1988 ; 12: 900-999
34. Sheps DS, Herbst MC, Hinderliter AL, Adams KF, Ekelund LG, O'Neil JJ, et al. Production of arrhythmias by elevated carboxyhemoglobin in patients with coronary artery disease. Ann Intern Med. 1990 ; 113: 343-351 (Pubitemid 20262819)
35. Dahms TE, Younis LT, Wiens RD, Zarnegar S, Byers SL, Chaitman BR. Effects of carbon monoxide exposure in patients with documented cardiac arrhythmias. J Am Coll Cardiol. 1993 ; 21: 442-450 (Pubitemid 23047929)
36. Edirisinghe I, Rahman I. Cigarette smoke-mediated oxidative stress, shear stress, and endothelial dysfunction: role of VEGFR2. Ann N Y Acad Sci. 2010 ; 1203: 66-72
37. Van Wagoner DR. Oxidative stress and inflammation in atrial fibrillation: role in pathogenesis and potential as a therapeutic target. J Cardiovasc Pharmacol. 2008 ; 52: 306-313
38. Ramlawi B, Otu H, Mieno S, Boodhwani M, Sodha NR, Clements RT, et al. Oxidative stress and atrial fibrillation after cardiac surgery: a case-control study. Ann Thorac Surg. 2007 ; 84: 1166-1172
39. Li J, Solus J, Chen Q, Rho YH, Milne G, Stein CM, et al. Role of inflammation and oxidative stress in atrial fibrillation. Heart Rhythm. 2010 ; 7: 438-444
40. Talukder MA, Johnson WM, Varadharaj S, Lian J, Kearns PN, El-Mahdy MA, et al. Chronic cigarette smoking causes hypertension, increased oxidative stress, impaired NO bioavailability, endothelial dysfunction, and cardiac remodeling in mice. Am J Physiol Heart Circ Physiol. 2011 ; 300: H388 - H396
41. Goldenberg I, Jonas M, Tenenbaum A, Boyko V, Matetzky S, Shotan A, et al. Bezafibrate Infarction Prevention Study Group. Current smoking, smoking cessation, and the risk of sudden cardiac death in patients with coronary artery disease. Arch Intern Med. 2003 ; 163: 2301-2305 (Pubitemid 37310190)
42. Goldenberg I, Moss AJ, McNitt S, Zareba W, Daubert JP, Hall WJ, et al. Multicenter automatic defibrillator implantation trial-II investigators. Cigarette smoking and the risk of supraventricular and ventricular tachyarrhythmias in high-risk cardiac patients with implantable cardioverter defibrillators. J Cardiovasc Electrophysiol. 2006 ; 17: 931-936
43. Engström G, Hedblad B, Janzon L, Juul-Möller S. Ventricular arrhythmias during 24-h ambulatory ECG recording: incidence, risk factors and prognosis in men with and without a history of cardiovascular disease. J Intern Med. 1999 ; 246: 363-372 (Pubitemid 29479918)
44. Vlietstra RE, Kronmal RA, Oberman A, Frye RL, Killip 3rd, T. Effect of cigarette smoking on survival of patients with angiographically documented coronary artery disease. Report from the CASS registry. JAMA. 1986 ; 255: 1023-1027 (Pubitemid 16164149)
45. Srivastava R, Blackstone EH, Lauer MS. Association of smoking with abnormal exercise heart rate responses and long-term prognosis in a healthy, population-based cohort. Am J Med. 2000 ; 109: 20-26 (Pubitemid 30608733)
46. Laustiola KE, Lassila R, Kaprio J, Koskenvuo M. Decreased betaadrenergic receptor density and catecholamine response in male cigarette smokers. A study of monozygotic twin pairs discordant for smoking. Circulation. 1988 ; 78: 1234-1240
47. Laustiola KE, Kotamaki M, Lassila R, Kallioniemi OP, Manninen V. Cigarette smoking alters sympathoadrenal regulation by decreasing the density of beta 2-adrenoceptors. A study of monitored smoking cessation. J Cardiovasc Pharmacol. 1991 ; 17: 923-928
48. Cryer PE, Haymond MW, Santiago JV, Shah SD. Norepinephrine and epinephrine release and adrenergic mediation of smoking-associated hemodynamic and metabolic events. N Engl J Med. 1976 ; 295: 573-577
49. Colucci WS, Ribeiro JP, Rocco MB, Quigg RJ, Creager MA, Marsh JD, et al. Impaired chronotropic response to exercise in patients with congestive heart failure. Role of postsynaptic beta-adrenergic desensitization. Circulation. 1989 ; 80: 314-323 (Pubitemid 19195740)
50. La Rovere MT, Bigger JT, Marcus FI, Mortara A, Schwartz PJ. Baroreflex sensitivity and heart rate variability in prediction of total cardiac mortality after myocardial infarction. Lancet. 1998 ; 351: 478-484 (Pubitemid 28070094)
51. Munjal S, Koval T, Muhammad R, Jin Y, Demmel V, Roethig HJ, et al. Heart rate variability increases with reductions in cigarette smoke exposure after 3 days. J Cardiovasc Pharmacol Ther. 2009 ; 14: 192-198
52. Heeringa J, Kors JA, Hofman A, van Rooij FJ, Witteman JC. Cigarette smoking and risk of atrial fibrillation: the Rotterdam Study. Am Heart J. 2008 ; 156: 1163-1169
53. Benjamin EJ, Levy D, Vaziri SM, D'Agostino RB, Belanger AJ, Wolf PA. Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. JAMA. 1994 ; 271: 840-844
54. Krahn AD, Manfreda J, Tate RB, Mathewson FA, Cuddy TE. The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study. Am J Med. 1995 ; 98: 476-484
55. Smith JG, Platonov PG, Hedblad B, Engström G, Melander O. Atrial fibrillation in the Malmö Diet and Cancer study: a study of occurrence, risk factors and diagnostic validity. Eur J Epidemiol. 2010 ; 25: 95-102
56. Psaty BM, Manolio TA, Kuller LH, Kronmal RA, Cushman M, Fried LP, et al. Incidence of and risk factors for atrial fibrillation in older adults. Circulation. 1997 ; 96: 2455-2461 (Pubitemid 27425856)
57. Buch P, Friberg J, Scharling H, Lange P, Prescott E. Reduced lung function and risk of atrial fibrillation in the Copenhagen City Heart Study. Eur Respir J. 2003 ; 21: 1012-1016 (Pubitemid 36675619)
58. Stewart S, Hart CL, Hole DJ, McMurray JJ. Population prevalence, incidence, and predictors of atrial fibrillation in the Renfrew/Paisley study. Heart. 2001 ; 86: 516-521 (Pubitemid 32999861)
59. Frost L, Hune LJ, Vestergaard P. Overweight and obesity as risk factors for atrial fibrillation or flutter: the Danish Diet, Cancer, and Health Study. Am J Med. 2005 ; 118: 489-495 (Pubitemid 40615472)
60. Wells AJ. Passive smoking as a cause of heart disease. J Am Coll Cardiol. 1994 ; 24: 546-554 (Pubitemid 24246560)
61. Heart rate variability: standards of measurement, physiological interpretation, and clinical use. Circulation. 1996 ; 93: 1043-1065
62. Pope CA, 3rd, Eatough DJ, Gold DR, Pang Y, Nielsen KR, Nath P, et al. Acute exposure to environmental tobacco smoke and heart rate variability. Environ Health Perspect. 2001 ; 109: 711-716 (Pubitemid 32791306)
63. Felber Dietrich D, Schwartz J, Schindler C, Gaspoz JM, Barthélémy JC, Tschopp JM, et al. (SAPALDIA-team). Effects of passive smoking on heart rate variability, heart rate and blood pressure: an observational study. Int J Epidemiol. 2007 ; 36: 834-840 (Pubitemid 47394152)
64. Chen CY, Chow D, Chiamvimonvat N, Glatter KA, Li N, He Y, et al. Short-term secondhand smoke exposure decreases heart rate variability and increases arrhythmia susceptibility in mice. Am J Physiol Heart Circ Physiol. 2008 ; 295: H632 - H639
65. Elahi MM, Flatman S, Matata BM. Tracing the origins of postoperative atrial fibrillation: the concept of oxidative stress-mediated myocardial injury phenomenon. Eur J Cardiovasc Prev Rehabil. 2008 ; 15: 735-741
66. Mariscalco G, Engström KG. Atrial fibrillation after cardiac surgery: risk factors and their temporal relationship in prophylactic drug strategy decision. Int J Cardiol. 2008 ; 129: 354-362
67. Villareal RP, Hariharan R, Liu BC, Kar B, Lee VV, Elayda M, et al. Postoperative atrial fibrillation and mortality after coronary artery bypass surgery. J Am Coll Cardiol. 2004 ; 43: 742-748 (Pubitemid 38296469)
68. El-Chami MF, Kilgo P, Thourani V, Lattouf OM, Delurgio DB, Guyton RA, et al. New-onset atrial fibrillation predicts long-term mortality after coronary artery bypass graft. J Am Coll Cardiol. 2010 ; 55: 1370-1376
69. Almassi GH, Schowalter T, Nicolosi AC, Aggarwal A, Moritz TE, Henderson WG, et al. Atrial fibrillation after cardiac surgery: a major morbid event?. Ann Surg. 1997 ; 226: 501-511
70. Mahoney EM, Thompson TD, Veledar E, Williams J, Weintraub WS. Cost-effectiveness of targeting patients undergoing cardiac surgery for therapy with intravenous amiodarone to prevent atrial fibrillation. J Am Coll Cardiol. 2002 ; 40: 737-745 (Pubitemid 34925621)
71. Mariscalco G, Engström KG. Are current smokers paradoxically protected against atrial fibrillation after cardiac surgery?. Nicotine Tob Res. 2009 ; 11: 58-63
72. Al-Sarraf N, Thalib L, Hughes A, Houlihan M, Tolan M, Young V, et al. The risk of arrhythmias following coronary artery bypass surgery: do smokers have a paradox effect?. Interact Cardiovasc Thorac Surg. 2010 ; 11: 550-555
73. Tiwari KK, Granov N, Bevilacqua S, Glauber M. Could effect of smoking guide us to a new treatment option for atrial fibrillation?. Interact Cardiovasc Thorac Surg. 2010 ; 11: 555-555